News

What’s Happening With HIMS Stock?
HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...
Hims to cut 4% of workforce amid ban on weight-loss drug copies
By Amina Niasse NEW YORK (Reuters) -Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as ...
Hims & Hers Health Is Building The Next Global Primary-Care Network
Hims & Hers (HIMS) doubles revenue, expands margins, and grows subscribers. Zava acquisition triples market potential, ...
Weight loss drugs, like Ozempic and Wegovy, are changing lives on Long Island — but at a crushing cost for some
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
pharmaphorum2d
Hims & Hers buys Zava to form European beachhead
The cash-based acquisition – the financial terms of which are not being disclosed – will expand Hims & Hers' presence in the ...
Wegovy Deal Makes Cofounder Of Hair Loss Pill Seller Hims A Billionaire
Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a fortune off the popularity of weight loss injections.
Wegovy discount: Price for weight-loss drug gets cut to $199, but there's a catch
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Seeking Alpha25d
Hims & Hers: Wegovy Deal Opens New Growth Chapter - Missed The Rally? Selling Puts Could Yield 30%
Hims & Hers Health rebounded from a 60% stock drop by partnering with Novo Nordisk, offering Wegovy at a competitive price, boosting accessibility and growth. Q1 earnings were exceptional with 111 ...
Hims Stock Surges 180%--Now It's Betting Big on Europe's $100B Weight-Loss Market
After experiencing high growth in the U.S. telehealth scene, Hims is taking its personalized obesity treatments ...